StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report released on Friday. The brokerage issued a hold rating on the stock.
TherapeuticsMD Trading Up 3.9 %
TXMD stock opened at $1.85 on Friday. TherapeuticsMD has a 1-year low of $1.43 and a 1-year high of $4.35. The business’s 50 day moving average is $1.96 and its 200-day moving average is $2.13.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last issued its quarterly earnings data on Friday, May 10th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $0.31 million during the quarter.
Institutional Inflows and Outflows
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Stories
- Five stocks we like better than TherapeuticsMD
- How to Evaluate a Stock Before Buying
- Top 3 Defense Stocks That Should Be on Your Radar
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- How to Use the MarketBeat Excel Dividend Calculator
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.